Articles with public access mandates - evdokia anagnostouLearn more
Not available anywhere: 29
Review
Use of psychotropic medication in children and adolescents with autism spectrum disorders
DL Coury, E Anagnostou, P Manning-Courtney, A Reynolds, L Cole, ...
Pediatrics 130 (Supplement_2), S69-S76, 2012
Mandates: Canadian Institutes of Health Research, Autism Speaks Inc, USA
Review
Clinical practice pathways for evaluation and medication choice for attention-deficit/hyperactivity disorder symptoms in autism spectrum disorders
R Mahajan, MP Bernal, R Panzer, A Whitaker, W Roberts, B Handen, ...
Pediatrics 130 (Supplement_2), S125-S138, 2012
Mandates: Autism Speaks Inc, USA
Review
Clinical trials in autism spectrum disorder: evidence, challenges and future directions
E Anagnostou
Current opinion in neurology 31 (2), 119-125, 2018
Mandates: US Department of Defense, US National Institutes of Health, Canadian …
Review
Practitioner review: Pharmacological treatment of attention‐deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: A systematic review and …
R Rodrigues, MC Lai, A Beswick, DA Gorman, E Anagnostou, P Szatmari, ...
Journal of Child Psychology and Psychiatry 62 (6), 680-700, 2021
Mandates: US Department of Defense, US National Institutes of Health, Canadian …
Review
A randomized, placebo-controlled trial of metformin for the treatment of overweight induced by antipsychotic medication in young people with autism spectrum disorder: open …
BL Handen, E Anagnostou, MG Aman, KB Sanders, J Chan, JA Hollway, ...
Journal of the American Academy of Child & Adolescent Psychiatry 56 (10 …, 2017
Mandates: US National Institutes of Health
Review
Widespread white matter differences in children and adolescents with autism spectrum disorder
VM Vogan, BR Morgan, RC Leung, E Anagnostou, K Doyle-Thomas, ...
Journal of autism and developmental disorders 46, 2138-2147, 2016
Mandates: Canadian Institutes of Health Research
Review
The effect of diagnosis, age, and symptom severity on cortical surface area in the cingulate cortex and insula in autism spectrum disorders
KAR Doyle-Thomas, A Kushki, EG Duerden, MJ Taylor, JP Lerch, ...
Journal of child neurology 28 (6), 732-739, 2013
Mandates: Autism Speaks Inc, USA
Review
Novel treatments in autism spectrum disorder
D Baribeau, J Vorstman, E Anagnostou
Current Opinion in Psychiatry 35 (2), 101-110, 2022
Mandates: Canadian Institutes of Health Research
Review
DNA methylation of the oxytocin receptor across neurodevelopmental disorders
MT Siu, SJ Goodman, I Yellan, DT Butcher, M Jangjoo, D Grafodatskaya, ...
Journal of autism and developmental disorders, 1-14, 2021
Mandates: Canadian Institutes of Health Research
Review
Effects of age and attention on auditory global–local processing in children with autism spectrum disorder
NEV Foster, T Ouimet, A Tryfon, K Doyle-Thomas, E Anagnostou, ...
Journal of autism and developmental disorders 46, 1415-1428, 2016
Mandates: Canadian Institutes of Health Research
Review
Efficacy and safety of balovaptan for socialisation and communication difficulties in autistic adults in North America and Europe: a phase 3, randomised, placebo-controlled trial
S Jacob, J Veenstra-VanderWeele, D Murphy, J McCracken, J Smith, ...
The Lancet Psychiatry 9 (3), 199-210, 2022
Mandates: Autism Speaks Inc, USA
Review
Sleep phenotype of individuals with autism spectrum disorder bearing mutations in the PER2 circadian rhythm gene
N Hoang, RKC Yuen, J Howe, I Drmic, P Ambrozewicz, C Russell, ...
American Journal of Medical Genetics Part A 185 (4), 1120-1130, 2021
Mandates: Canadian Institutes of Health Research, Genome Canada, Autism Speaks Inc, USA
Review
Medical conditions and demographic, service and clinical factors associated with atypical antipsychotic medication use among children with an autism spectrum disorder
JK Lake, D Denton, Y Lunsky, AM Shui, J Veenstra-VanderWeele, ...
Journal of autism and developmental disorders 47, 1391-1402, 2017
Mandates: US National Institutes of Health, Autism Speaks Inc, USA
Review
Statistical persistence and timing characteristics of repetitive circle drawing in children with ASD
A Fleury, A Kushki, N Tanel, E Anagnostou, T Chau
Developmental neurorehabilitation 16 (4), 245-254, 2013
Mandates: Canadian Institutes of Health Research
Review
Characterizing the ASD–ADHD phenotype: Measurement structure and invariance in a clinical sample
AD Krakowski, KT Cost, P Szatmari, E Anagnostou, J Crosbie, ...
Journal of Child Psychology and Psychiatry 63 (12), 1534-1543, 2022
Mandates: US Department of Defense, US National Institutes of Health
Review
Emotional face processing in autism spectrum disorder: Effects in gamma connectivity
K Safar, V Yuk, SM Wong, RC Leung, E Anagnostou, MJ Taylor
Biological Psychology 149, 107774, 2020
Mandates: Canadian Institutes of Health Research
Review
Indices of repetitive behaviour are correlated with patterns of intrinsic functional connectivity in youth with autism spectrum disorder
JM Traynor, KAR Doyle-Thomas, LC Hanford, NE Foster, A Tryfon, ...
Brain research 1685, 79-90, 2018
Mandates: US National Institutes of Health
Review
Altered connectivity during a false-belief task in adults with autism spectrum disorder
V Yuk, E Anagnostou, MJ Taylor
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 5 (9), 901-912, 2020
Mandates: Canadian Institutes of Health Research
Review
Design and subject characteristics in the federally-funded citalopram trial in children with pervasive developmental disorders
L Scahill, JT McCracken, K Bearss, F Robinson, E Hollander, B King, ...
Journal of autism and developmental disorders 42, 432-440, 2012
Mandates: US National Institutes of Health
Review
Pharmacogenetics of metformin for medication-induced weight gain in autism spectrum disorder
D Garfunkel, EA Anagnostou, MG Aman, BL Handen, KB Sanders, ...
Journal of child and adolescent psychopharmacology 29 (6), 448-455, 2019
Mandates: US National Institutes of Health, Autism Speaks Inc, USA
Publication and funding information is determined automatically by a computer program